家禽药品市场－全球产业规模、份额、趋势、机会和预测（按品种、产品、疾病、配销通路、地区和竞争细分，2020-2030 年）

2024 年全球家禽药品市场规模为 67.8 亿美元，预计到 2030 年将达到 101 亿美元，复合年增长率为 6.84%。随着家禽业在满足全球对肉类和蛋类等高蛋白食品日益增长的需求方面继续发挥关键作用，全球家禽药品市场正在稳步扩张。商业化家禽养殖的成长和兽医学的进步，对有效的治疗和预防解决方案的需求强劲。对改善动物健康管理的需求，加上禽流感、新城疫和球虫病等家禽相关疾病的盛行率上升，进一步推动了市场的发展。为了保持鸡群生产力并最大限度地降低死亡率，疫苗、药物和饲料添加剂的使用日益增多，这鼓励了人们对这一领域的更多投资。消费者对高品质家禽产品的强烈偏好也导致人们更加关註生物安全和先进的医疗保健实践，从而刺激了家禽药品的发展。

主要成长动力之一是已开发国家和发展中国家禽肉消费量的激增，这得益于禽肉价格实惠且营养丰富。这种消费成长给家禽生产者带来了维持禽群健康的巨大压力，从而催生了对预防和治疗药物的需求。由于对抗生素抗药性的担忧，一个影响市场发展的突出趋势是，人们越来越多地转向抗生素的替代解决方案，例如益生菌、植物性添加剂和疫苗。诊断技术和精准兽医学的进步也使得早期疾病检测和针对性治疗成为可能，从而提高了家禽健康管理的效率。另一个日益增长的趋势是采用综合健康管理方案，将疫苗接种、营养补充剂和卫生规范相结合，以提高家禽生产力并减少损失。

儘管成长前景强劲，但市场仍面临挑战，这可能会在预测期内限制其潜力。先进家禽药品和疫苗的高成本仍然是一个障碍，尤其对于价格敏感型经济体的中小型养殖户而言。有关兽药（尤其是抗生素）审批和使用的严格监管框架也给製造商带来了合规挑战。人们对抗生素抗药性的担忧日益加剧，促使监管更加严格，这可能会影响某些常规药物的采用。此外，在可负担性和创新性之间保持平衡仍然是行业利益相关者面临的关键挑战。确保有效家禽药品的广泛可及性，同时解决环境和食品安全问题，对于维持全球家禽药品市场的长期成长仍然至关重要。

关键市场驱动因素

禽肉和蛋类消费量上升

主要市场挑战

先进兽药价格高昂

主要市场趋势

向无抗生素家禽生产转变

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球家禽药品市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依种类（鸡、土耳其、鸭、其他）
  • 副产品（生物製剂、药品、药物饲料添加剂）
  • 依疾病（新城疫、传染性支气管炎、传染性法氏囊病、球虫病、沙门氏菌病、马立克氏病、其他）
  • 依配销通路（兽医院及诊所、电子商务、线下零售店、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美家禽药品市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲家禽药品市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太家禽药品市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲家禽药品市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲家禽药品市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier SA
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Poultry Medicine Market was valued at USD 6.78 Billion in 2024 and is expected to reach USD 10.10 Billion by 2030 with a CAGR of 6.84%. The Global Poultry Medicine Market is witnessing steady expansion as the poultry industry continues to play a critical role in meeting the rising global demand for protein-rich food products such as meat and eggs. Growth in commercial poultry farming and advancements in veterinary medicine are creating strong demand for effective treatment and preventive solutions. The need for improved animal health management, coupled with the rising prevalence of poultry-related diseases such as avian influenza, Newcastle disease, and coccidiosis, is further boosting the market. Increasing adoption of vaccines, pharmaceuticals, and feed additives to maintain flock productivity and minimize mortality rates is encouraging greater investments in this segment. Strong consumer preference for high-quality poultry products is also leading to heightened focus on biosecurity and advanced healthcare practices, stimulating the growth of poultry medicine.

One of the major growth drivers is the surge in poultry meat consumption across both developed and developing nations, driven by its affordability and nutritional benefits. This rising consumption places significant pressure on poultry producers to maintain flock health, thus generating demand for preventive and therapeutic medicines. A prominent trend shaping the market is the increasing shift toward alternative solutions to antibiotics, such as probiotics, phytogenic additives, and vaccines, due to concerns around antimicrobial resistance. Technological advancements in diagnostics and precision veterinary medicine are also enabling early disease detection and targeted treatment, enhancing efficiency in poultry health management. Another trend gaining momentum is the adoption of integrated health management programs that combine vaccination, nutritional supplements, and hygiene practices to improve poultry productivity and reduce losses.

Despite strong growth prospects, the market faces challenges that could restrain its potential during the forecast period. High costs associated with advanced poultry medicines and vaccines remain a barrier, especially for small and medium-scale farmers in price-sensitive economies. Stringent regulatory frameworks concerning the approval and use of veterinary medicines, particularly antibiotics, also present compliance challenges for manufacturers. Rising concerns over antimicrobial resistance are prompting stricter controls, which may impact the adoption of certain conventional medicines. Moreover, maintaining the balance between affordability and innovation continues to be a key challenge for industry stakeholders. Ensuring widespread accessibility of effective poultry medicines while addressing environmental and food safety concerns will remain critical for sustaining long-term growth in the Global Poultry Medicine Market.

Key Market Drivers

Rising Poultry Meat and Egg Consumption

Rising poultry meat and egg consumption is a pivotal driver in the Global Poultry Medicine Market, as growing demand directly influences the adoption of advanced healthcare solutions for flocks. Poultry has become the most affordable and accessible source of animal protein, widely consumed due to its favorable nutritional profile, quick production cycle, and versatility in diets. Government statistics highlight the strength of this trend. In India, total egg production rose to 142.77 billion eggs in FY 2023-24, representing a 3.18% increase over the previous year, while poultry meat output reached 10.25 million tonnes, up by nearly 5% according to official data released by the Department of Animal Husbandry and Dairying. Per capita availability of eggs in India stood at 103 eggs per annum, which remains below the National Institute of Nutrition's recommendation, suggesting considerable growth potential in consumption.

Globally, the FAO-OECD Agricultural Outlook 2025-2034 projects poultry meat consumption to rise to 173 million tonnes (ready-to-cook basis) by 2034, accounting for about 62% of the total additional meat consumed worldwide. This growth reflects shifting dietary patterns as consumers in both developed and developing countries favor poultry over red meats due to affordability and health perceptions. In the United States, USDA data shows poultry remains a core component of the national diet, with per capita consumption consistently higher than beef and pork, reflecting strong cultural and nutritional preferences.

This steady rise in poultry meat and egg consumption underscores the need for effective disease prevention and treatment strategies. Producers must manage infectious risks while ensuring flock productivity and food safety. The growing reliance on veterinary medicines such as vaccines, biologics, and feed-based solutions is directly tied to this consumption boom, making rising demand for poultry products a crucial long-term growth driver for the market.

Key Market Challenges

High Cost of Advanced Veterinary Medicines

The high cost of advanced veterinary medicines represents one of the most significant challenges for the Global Poultry Medicine Market, particularly in regions where poultry farming is driven by small and medium-scale producers. Modern pharmaceuticals, biologics, and next-generation vaccines often involve extensive research, development, and regulatory approval processes, which substantially increase their market price. For commercial farms with large-scale operations, these costs may be manageable due to higher revenue streams, but for smaller producers, the financial burden becomes a barrier to adoption. Limited access to cost-effective alternatives leaves many farmers reliant on traditional or less effective solutions, increasing the risk of disease outbreaks, higher mortality, and reduced productivity.

The financial constraints also limit the ability of farmers to implement preventive healthcare programs, as they often prioritize immediate cost savings over long-term benefits. This creates a cycle were inadequate investment in quality medicines results in higher vulnerability to disease, leading to economic losses that could have been avoided with advanced treatments. The disparity in affordability also impacts market penetration for veterinary pharmaceutical companies, as demand for innovative products is concentrated in developed economies while adoption in emerging markets remains limited. Balancing innovation with affordability is a pressing challenge, as manufacturers must continue to invest in developing novel solutions to address issues like antimicrobial resistance and emerging poultry diseases, while ensuring that their products remain accessible to producers in price-sensitive regions. Without cost-effective strategies such as tiered pricing models, local manufacturing partnerships, or government-supported subsidies, the high cost of advanced veterinary medicines may slow down the widespread adoption of innovative healthcare practices in poultry farming, ultimately restricting the market's long-term growth potential.

Key Market Trends

Shift Toward Antibiotic-Free Poultry Production

The Global Poultry Medicine Market is experiencing a significant transformation driven by the industry-wide shift toward antibiotic-free poultry production. Growing concerns about antimicrobial resistance (AMR) and the presence of antibiotic residues in meat and eggs have prompted regulators, consumers, and producers to rethink their approach to poultry health management. Consumers are increasingly demanding clean-label, residue-free poultry products, compelling producers to seek alternatives that maintain bird health without compromising food safety. Governments across several regions have introduced stricter policies restricting the use of growth-promoting antibiotics in poultry farming, creating a strong push toward sustainable and responsible practices. This shift has created rising demand for probiotic formulations, phytogenic feed additives, vaccines, and herbal medicines, which offer effective disease prevention and immunity enhancement while aligning with consumer preferences.

Producers are also investing in improved biosecurity measures, nutritional optimization, and flock management strategies to reduce reliance on antibiotics. The market is witnessing increased innovation in natural and biologic-based solutions that address respiratory, digestive, and immunological challenges without contributing to AMR. Veterinary pharmaceutical companies are expanding research collaborations to develop next-generation alternatives that can be scaled effectively for commercial poultry operations. The trend toward antibiotic-free production is not only reshaping product portfolios but is also emerging as a competitive differentiator in the global poultry industry.

Key Market Players

• Boehringer Ingelheim International GmbH
• Zoetis Services LLC
• Vaxxinova International BV
• Merck & Co., Inc.
• Calier S.A.
• Elanco Animal Health Incorporated
• Hester Biosciences Limited
• Ceva Sante Animale
• Phibro Animal Health Corporation
• Kemin Industries, Inc.

Report Scope:

In this report, the Global Poultry Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Medicine Market, By Species:

• Chicken
• Turkey
• Ducks
• Others

Poultry Medicine Market, By Product:

• Biologics
• Pharmaceuticals
• Medicated Feed Additives

Poultry Medicine Market, By Disease:

• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Coccidiosis
• Salmonella
• Marek's Disease
• Others

Poultry Medicine Market, By Distribution Channel:

• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

Poultry Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Medicine Market.

Available Customizations:

Global Poultry Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Poultry Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Species (Chicken, Turkey, Ducks, Others)
  • 5.2.2. By Product (Biologics, Pharmaceuticals, Medicated Feed Additives)
  • 5.2.3. By Disease (Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Coccidiosis, Salmonella, Marek's Disease, Others)
  • 5.2.4. By Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Offline Retail Stores, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Poultry Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Species
  • 6.2.2. By Product
  • 6.2.3. By Disease
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Species
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease
      • 6.3.1.2.4. By Distribution Channel
  • 6.3.2. Mexico Poultry Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Species
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease
      • 6.3.2.2.4. By Distribution Channel
  • 6.3.3. Canada Poultry Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Species
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease
      • 6.3.3.2.4. By Distribution Channel

7. Europe Poultry Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Species
  • 7.2.2. By Product
  • 7.2.3. By Disease
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Poultry Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Species
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease
      • 7.3.1.2.4. By Distribution Channel
  • 7.3.2. Germany Poultry Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Species
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease
      • 7.3.2.2.4. By Distribution Channel
  • 7.3.3. United Kingdom Poultry Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Species
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease
      • 7.3.3.2.4. By Distribution Channel
  • 7.3.4. Italy Poultry Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Species
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease
      • 7.3.4.2.4. By Distribution Channel
  • 7.3.5. Spain Poultry Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Species
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease
      • 7.3.5.2.4. By Distribution Channel

8. Asia-Pacific Poultry Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Species
  • 8.2.2. By Product
  • 8.2.3. By Disease
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Poultry Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Species
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease
      • 8.3.1.2.4. By Distribution Channel
  • 8.3.2. India Poultry Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Species
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease
      • 8.3.2.2.4. By Distribution Channel
  • 8.3.3. South Korea Poultry Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Species
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease
      • 8.3.3.2.4. By Distribution Channel
  • 8.3.4. Japan Poultry Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Species
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease
      • 8.3.4.2.4. By Distribution Channel
  • 8.3.5. Australia Poultry Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Species
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease
      • 8.3.5.2.4. By Distribution Channel

9. South America Poultry Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Species
  • 9.2.2. By Product
  • 9.2.3. By Disease
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Poultry Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Species
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease
      • 9.3.1.2.4. By Distribution Channel
  • 9.3.2. Argentina Poultry Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Species
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease
      • 9.3.2.2.4. By Distribution Channel
  • 9.3.3. Colombia Poultry Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Species
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease
      • 9.3.3.2.4. By Distribution Channel

10. Middle East and Africa Poultry Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Species
  • 10.2.2. By Product
  • 10.2.3. By Disease
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Poultry Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Species
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease
      • 10.3.1.2.4. By Distribution Channel
  • 10.3.2. Saudi Arabia Poultry Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Species
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease
      • 10.3.2.2.4. By Distribution Channel
  • 10.3.3. UAE Poultry Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Species
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease
      • 10.3.3.2.4. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Zoetis Services LLC
• 15.3. Vaxxinova International BV
• 15.4. Merck & Co., Inc.
• 15.5. Calier S.A.
• 15.6. Elanco Animal Health Incorporated
• 15.7. Hester Biosciences Limited
• 15.8. Ceva Sante Animale
• 15.9. Phibro Animal Health Corporation
• 15.10. Kemin Industries, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer